It has been reported that HDAC5 modulates PD‐L1 expression and cancer immunity via p65 deacetylation in pancreatic cancer, and vorinostat decreases PD‐L1 expression in the triple‐negative breast cancer cell line [45, 46]. Here, CD274 is linked to cancer.